ChimowitzMILynnMJHowlett-SmithH: Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med.2005; 352: 1305–1316.
2.
FiorellaDLevyEITurkAS. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: Periprocedural results. Stroke. 2007; 38: 881–887. Epub 2007 Feb 8.
KurreWBerkefeldJBrasselF. INTRASTENT Study Group. In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: Results from the INTRASTENT multicentric registry. Stroke. 2010; 41: 494–498.
6.
FiehlerJJansenOBergerJ. Differences in complication rates among the centres in the SPACE study. Neuroradiology. 2008; 50: 1049–1053.
7.
SuriMFTariqNSiddiqF. Intracranial angioplasty and/or stent placement in octogenarians is associated with a threefold greater risk of periprocedural stroke or death. J Endovasc Ther.2010; 17: 314–319.
8.
NahabFLynnMJKasnerSE. NIH Multicenter Wingspan Intracranial Stent Registry Study Group. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology. 2009; 72: 2014–2019. Epub 2009 Mar 18.
9.
LeeDKKimJSKwonSU. Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: Early diffusion-weighted imaging study. Stroke. 2005; 36: 2583–2588.
